Last $8.34 USD
Change Today +0.01 / 0.12%
Volume 501.2K
As of 8:10 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jon P. Stonehouse

Chief Executive Officer, President and Executive Director, BioCryst Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 3 different industries.

See Board Relationships
52$1,975,287
As of Fiscal Year 2013

Background*

Mr. Jon P. Stonehouse has been the Chief Executive Officer of BioCryst Pharmaceuticals, Inc. since joining in January 8, 2007 and also its President since July 13, 2007. Mr. Stonehouse has over 20 years strong commercialization, Financial transaction, Business development and Management experience. Previously, he served as Senior Vice President of Corporate Development of Merck KGaA., since July 2002 and was responsible for global licensing and business development, ...

Read Full Background

Corporate Headquarters*

4505 Emperor Boulevard
Durham, North Carolina 27703

United States

Phone: 919-859-1302
Fax: 919-859-1314

Board Members Memberships*

2007-Present
Chief Executive Officer, President and Executive Director

Education*

BS
University of Minnesota

Other Affiliations*

Annual Compensation*

Salary$475,716
Total Annual Compensation$475,716

Stock Options*

Restricted Stock Awards$88,892
All Other Compensation$13,655
Exercised Options Value$84,412
Exercisable Options Value$1,449,500
Unexercisable Options Value$2,968,371
Total Value of Options$4,717,283

Total Compensation*

Total Annual Cash Compensation$655,872
Total Short Term Compensation$475,716
Other Long Term Compensation$102,547
Total Calculated Compensation$1,975,287
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCRX:US $8.34 USD +0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gustav A. Christensen Chief Executive Officer, President and Director
Dyax Corp.
$615.6K
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Sijmen de Vries M.D., MBAChief Executive Officer and Member of Management Board
Pharming Group NV
€594.0K
Flemming Ornskov M.D., MBA, MPHChief Executive Officer and Director
Shire plc
$2.7M
Joji Nakayama Chief Executive Officer, President and Representative Director
Daiichi Sankyo Company, Limited
--
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOCRYST PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.